Live · updated 8 minutes ago · 26 stories in 24h

← Stream
AI & Tech Unverified First seen

Isomorphic Labs raises $5 billion Series C led by Greenoaks and Sequoia

Isomorphic Labs, the AI drug-design company spun out of Google DeepMind, has raised $5 billion in Series C funding, according to The Defiant and HedgeCo.Net. Both posts report the round was co-led by Greenoaks and Sequoia Capital, and The Defiant adds that Alphabet invested again as the company prepares its first therapeutic programs for clinical trials.

Why “Unverified”

  • 2 independent sources (The Defiant, HedgeCo.Net), but no primary confirmation

2 independent source groups across 2 posts · evidence score 71/100. How labels work

What the sources claim

  1. Isomorphic Labs raised $5 billion in Series C funding.

    “has raised $5 billion in Series C funding”
    HedgeCo.Net
  2. The Series C round was co-led by Greenoaks and Sequoia Capital.

    “The round was co-led by Greenoaks and Sequoia Capital”
    HedgeCo.Net
  3. Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials.

    “Greenoaks and Sequoia co-led the Series C as Isomorphic prepares its first therapeutic programs for clinical trials”
    The Defiant
  4. Alphabet invested again in the round.

    “with Alphabet investing again”
    The Defiant
  5. Isomorphic Labs is the AI drug-design company spun out of Google DeepMind in 2021.

    “the AI drug-design company spun out of Google DeepMind in 2021”
    HedgeCo.Net

Sources

More in AI & Tech

All AI & Tech stories →

Embed this page

Summary and claims extracted by AI with prompt analyze-story@5 on 2026-11-18 12:00 UTC. Labels are computed from the sources, not by the model.